ISHARES MSCI EMERGING MARKETS ETF News

Technically speaking, the major U.S. benchmarks are off to a constructive July start despite persistently uneven price action, writes Michael Ashbaugh.

Leveraged ETFs sometimes have an unpredictable behavior. We illustrate our point with 22 ETFs tracking various indexes. Then we focus on the behavior of SPXU.

Complacency reigns among stock investors as new all-time highs remain within sight. A new risk is emerging for stocks as the COVID-19 crisis unfolds. Navigating

A central bank's ability to fight inflation is constrained by the sovereign's ability to weather an economic slowdown and service its debt. Some EMs have earned

Our base case is that the global economic recovery in its initial stages will be slow and uneven. We assume there will be a gradual easing of lockdowns and a gr

Weaker healthcare systems in Emerging Market (EM) countries resulted in stricter lockdowns compared to developed markets. E-commerce and fintech firms in EM ste

China is increasingly under the magnifying glass for its role in spreading misinformation about COVID-19 - or at the very least failing to properly warn the glo

The emerging markets fund has reversed at resistance, raising odds for renewed downside that could generate timely short sale profits.

A record amount of stimulus has supported equity markets, while the economy continues to face serious issues. The U.S. has higher unemployment rates than many d

The entire market is convinced that the current rally is due to the recent Fed action. History does not support such a conclusion. One has to understand the tru

In the absence of a medical solution, the strength of the recovery is highly uncertain and the impact on sectors and countries uneven. Compared to our April Wor

Chris Konstantinos, RiverFront Investment Group's Chief Investment Strategist, joined The Final Round to give his take on the markets and his outlook for second quarter earnings.

Martin Currie Emerging Markets Fund Portfolio Manager Andrew Mathewson joins Yahoo Finance’s On The Move panel to break down when investors should buy into emerging markets.

Reality is finally biting.  Will U.S. stocks take notice? Exploring the implications of monetary morphine from the U.S. Federal Reserve on today's U.S. stock ma

China is increasingly under the magnifying glass for its role in spreading misinformation about COVID-19 - or at the very least failing to properly warn the glo